Relay Therapeutics, Inc. (RLAY) Operating income 2019–2025
Relay Therapeutics, Inc. (RLAY) annual operating income history from SEC filings — each fiscal year as reported.
-$302.7MFY2025 · since FY2019: -$84.0M → -$302.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$302.7M | +18.7% |
| FY2024 | -$372.5M | +0.1% |
| FY2023 | -$373.0M | -24.6% |
| FY2022 | -$299.3M | +17.9% |
| FY2021 | -$364.7M | -553.6% |
| FY2020 | -$55.8M | +33.6% |
| FY2019 | -$84.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RLAY financial trends
RLAY RevenueRLAY Net incomeRLAY Net marginRLAY Gross profitRLAY Gross marginRLAY Operating marginRLAY Operating cash flowRLAY Free cash flowRLAY Capital expendituresRLAY Return on equityRLAY Stock buybacksRLAY Dividends paidRLAY Total assetsRLAY Total liabilitiesRLAY Shareholders’ equityRLAY overview →